Challenges in Diagnosing and Treatment Plan of Mucormycosis Pre and Post Pandemic

Rishana Ashraf; Anitha S; Sivachandran; Aravindhan; Sathyakumar; Dr. K.T. Magesh

doi:10.36948/ijfmr.2024.v06i04.10508

Challenges in Diagnosing and Treatment Plan of Mucormycosis Pre and Post Pandemic

Author(s)	Rishana Ashraf, Anitha S, Sivachandran, Aravindhan, Sathyakumar, Dr. K.T. Magesh
Country	india
Abstract	With the current pandemic sweeping the world, science and medicine are up against enemies they have never faced before or opponents that are weaker than themselves—viruses and finally other biotic beings. Researchers are working to detect and eradicate COVID-19 variants, but opportunistic fungal infections caused by other innocuous species are rearing their ugly heads. Mucorale species cause mucormycosis, sometimes known as "Black Fungus," an aggressive opportunistic fungal illness. It spreads via blood vessels and causes necrosis, ischemia, and thrombosis. Particularly vulnerable are those who already have immunosuppressive conditions, such as diabetes mellitus, cancer, or long-term immunosuppressive pharmaceutical use.Coronavirus disease-2019 (COVID-19)-associated mucormycosis proved to be devastating because of its high death rate.Since the primary care physician is often the patient's first and often their only point of contact with a healthcare professional (especially in poor nations), they are vital to the diagnosis and treatment of this illness. To reduce mortality, early detection and diagnosis are crucial, as are preventative measures to halt the growth of the brain. A multidisciplinary approach from several professions is necessary for effective diagnosis and treatment. Surgical debridement, antifungal treatment, and excision of the affected regions are the protocols that need to be followed. Post-operative anomalies result in impairments related to phonetics, function, and appearance. Positive outcomes have been observed in congenital abnormality prosthetic rehabilitation, especially in elderly and immunocompromised individuals.
Keywords	Covid19, mucormycosis,covidassociated,mucormycosis(CAM),immunocompromised, diabetes,pandemic.
Field	Medical / Pharmacy
Published In	Volume 6, Issue 4, July-August 2024
Published On	2024-07-28
Cite This	Challenges in Diagnosing and Treatment Plan of Mucormycosis Pre and Post Pandemic - Rishana Ashraf, Anitha S, Sivachandran, Aravindhan, Sathyakumar, Dr. K.T. Magesh - IJFMR Volume 6, Issue 4, July-August 2024. DOI 10.36948/ijfmr.2024.v06i04.10508
DOI	https://doi.org/10.36948/ijfmr.2024.v06i04.10508
Short DOI	https://doi.org/gt5hn4

View / Download PDF File

E-ISSN 2582-2160

doi

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads

Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 6 Cover Page Vol 6 Isu 5 Cover Page Vol 6 Isu 4

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9898-5948-55	editor@ijfmr.com

International Journal For Multidisciplinary Research

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Challenges in Diagnosing and Treatment Plan of Mucormycosis Pre and Post Pandemic

Share this